Alena Gros

10PUBLICATIONS
112CO-AUTHORS
ChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 29, 2026
Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2.

|Mar 26, 2026
Enhancing Proteasome Activity in T Cells Alleviates Exhaustion and Improves Antitumor Immunity.

Ander de Blas, Massimo Andreatta, Asier Antoñana-Vildosola

|May 19, 2025
A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer - The MONEO Study.

Maria Alsina, Guillermo Villacampa, Carlos de Andrea

|Jan 29, 2025
Unlocking the potential of engineered immune cell therapy for solid tumors.

Víctor Albarrán-Fernández, Laura Angelats, Julio Delgado

|Jan 24, 2024
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2.

Selim Chaib, José Alberto López-Domínguez, Marta Lalinde-Gutiérrez

|Mar 08, 2023
Neoantigen-targeted CD8<sup>+</sup> T cell responses with PD-1 blockade therapy.

Cristina Puig-Saus, Barbara Sennino, Songming Peng

Pageof 2

Frequent Collaborators

4 joint publications

Andrea Garcia-Garijo

3 joint publications

María Abad

3 joint publications

Manuel Serrano

3 joint publications

José Alberto López-Domínguez